Published in Nefrologia on January 01, 2011
Initial clinical presentation of Takotsubo cardiomyopathy with-a focus on electrocardiographic changes: A literature review of cases. World J Cardiol (2013) 0.80
Clinical features of patients with stress-induced cardiomyopathy associated with renal dysfunction: 7 case series in single center. BMC Nephrol (2013) 0.78
Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial. Kidney Int (2007) 3.52
Bloodstream infections in patients with kidney disease: risk factors for poor outcome and mortality. J Hosp Infect (2013) 1.55
[Calciphylaxis: fatal complication of cardiometabolic syndrome in patients with end stage kidney disease]. Nefrologia (2008) 1.47
Compliance with mineral metabolism targets in haemodialysis patients: moving backwards? Blood Purif (2013) 1.40
The phase angle of the electrical impedance is a predictor of long-term survival in dialysis patients. Nefrologia (2011) 1.18
Renal vascular disease in the elderly. Kidney Int Suppl (1998) 0.90
High-speed free-space quantum key distribution system for urban daylight applications. Appl Opt (2013) 0.85
Peritoneal mucormycosis in a patient receiving continuous ambulatory peritoneal dialysis. Am J Kidney Dis (1989) 0.82
Genetic position of Valencia (Spain) in the Mediterranean basin according to Alu insertions. Am J Hum Biol (2006) 0.81
Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena. Proc Eur Dial Transplant Assoc (1983) 0.79
Prevalence of hypertension in renal disease. Nephrol Dial Transplant (2001) 0.79
[Therapeutic guidelines fulfillment in clinical practice in patients with chronic kidney disease (CKD)]. Nefrologia (2007) 0.78
[Prolonged acute renal failure and severe polyradiculopathy in ethylene glycol intoxication]. Nefrologia (2006) 0.78
Serum calcium and parathyroid hormone derangements in rhabdomyolysis. Nephron (1989) 0.77
[Pharmacogenetics of angiotensin system in non diabetic nephropathy]. Nefrologia (2005) 0.77
High-sensitivity troponin T levels in kidney transplant recipients. Transplant Proc (2012) 0.77
The non-casual relation between eosinophilia and thrombotic microangiopathy. Transfus Apher Sci (2012) 0.77
Adolescents with bulimic and nonbulimic eating disorders. J Adolesc Health Care (1985) 0.76
[Risk of cardiovascular disease associated to chronic renal disease. Prevalence and control degree of classical risk factors]. Nefrologia (2005) 0.76
Monitoring of circulating antibodies in a renal transplantation population: preliminary results. Transplant Proc (2012) 0.76
[Dialysis inclusion criteria and early mortality]. Nefrologia (2001) 0.76
Acute renal failure and rhabdomyolysis following cocaine abuse. Nephron (1990) 0.75
Brachial-jugular polytetrafluoroethylene fistulas for hemodialysis. Am J Kidney Dis (1990) 0.75
Plasma exchange in the treatment of vascular rejection. Relationship between histological changes and therapeutic response. Transplant Proc (1987) 0.75
Microsatellites and Alu elements from the human MHC in Valencia (Spain): analysis of genetic relationships and linkage disequilibrium. Int J Immunogenet (2011) 0.75
[Clinical research based nephrology (bases for the constitution of an Evidence Based Nephrology Group in the Spanish Society of Nephrology)]. Nefrologia (2006) 0.75
Acute renal failure after bacteraemia and endocarditis. Nephrol Dial Transplant (2001) 0.75
Tuberculous peritonitis in patients on CAPD. Contrib Nephrol (1991) 0.75
[Bone disease in maintenance hemodialysis. Clinical, biochemical and radiological correlates]. Rev Clin Esp (1981) 0.75
[Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?]. An Med Interna (1998) 0.75
[Cellular and humoral immunity in patients on hemodialysis]. Rev Clin Esp (1980) 0.75
[Cerebral moya-moya disease with bilateral kidney infarction (author's transl)]. Med Clin (Barc) (1981) 0.75
[Renal arteriography during heart catheterization: 2 explorations with the price of one]. Nefrologia (2000) 0.75
[What features show patients referred for the first time to an outpatient nephrology clinic?]. Nefrologia (2005) 0.75
Early creation of pre-dialysis vascular access: Is it justified? J Vasc Access (2007) 0.75
[Metabolic syndrome in patients with essential hypertension]. Nefrologia (2003) 0.75
[Temporary catheter at dialysis onset: quality indicator of pre-dialysis care]. Nefrologia (2006) 0.75
[Progression of hyperparathyroidism during hemodialysis. Response to conservative treatment]. Rev Clin Esp (1982) 0.75
[Acute unilateral pulmonary edema in patients with chronic renal insufficiency]. Rev Clin Esp (1981) 0.75
[Atheroembolism in transplanted kidney]. Nefrologia (2009) 0.75
[Hyperparathyroidism after kidney transplant, its relation to kidney function and ionic calcium]. Rev Clin Esp (1980) 0.75
[Vasculitis in elderly patients associated to ANCA]. Nefrologia (2003) 0.75
Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs. Nephrol Dial Transplant (2001) 0.75
[Why early referral to the nephrologist of patients with diabetic nephropathy is necessary?]. Rev Clin Esp (1999) 0.75
[Renal insufficiency is an important cardiovascular risk factor]. Nefrologia (2002) 0.75
[Evaluation of efficacy of darbepoetin alfa administered once monthly as treatment of anemia in predialysis patients with chronic kidney disease]. Nefrologia (2005) 0.75
[Pre-dialysis vascular access. Does the evidence justify it?]. Nefrologia (2001) 0.75
[Why is an early referral to a consult with a nephrologist necessary for patients with diabetic nephropathy?]. Aten Primaria (1999) 0.75
[Risk factors in the development and progression of end-stage renal failure, the 21st century epidemic]. Nefrologia (2001) 0.75
Improving the visualization of the Pareto-optimal front for the multi-response optimization of chromatographic determinations. Anal Chim Acta (2010) 0.75
[Dyspnea caused by Coxiella Burnetii]. Semergen (2012) 0.75
[43 cycles of anabolic steroid treatment studied in athletes: the uses and secondary effects]. Rev Clin Esp (2000) 0.75
Acquired immunodeficiency syndrome in dialysis. Nephron (1988) 0.75
[Treatment with 1-alpha hydroxy vitamin D3 of bone disease in hemodialysis. Therapeutic results and complications]. Rev Clin Esp (1980) 0.75